Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 1, 2011
[Current S3 guidelines on surgical treatment of gastric carcinoma]H-J Meyer, A H Hölscher, F Lordick, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1990
HTK-solution (Bretschneider) for human liver transplantation. First clinical experiencesG Gubernatis, R Pichlmayr, P Lamesch, et al.
Agents and Actions|November 1, 1981
Histamine content in human kidneys with hypernephroid carcinoma. Is there a pathophysiological mechanism?H J Reimann, R Tauber, P Wendt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagusM Stahl, H Wilke, H J Meyer, et al.
Investigational New Drugs|February 1, 1990
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac riskH Wilke, P Preusser, U Fink, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Effects of cytokines on in vitro colony formation of primary human tumour specimensM Joraschkewitz, H Depenbrock, M Freund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatinH Wilke, P Preusser, U Fink, et al.
Seminars in Oncology|February 1, 1990
New developments in the treatment of gastric carcinomaH Wilke, P Preusser, U Fink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagusA Harstrick, C Bokemeyer, P Preusser, et al.
Seminars in Oncology|April 1, 1992
Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancerH Wilke, M Stahl, H J Schmoll, et al.
Pageof 19